Professor Gino Martini is the Chief Executive for the Precision Health Technologies Accelerator (PHTA) which is the University of Birmingham’s signature health and life sciences research facility, providing approximately 70,000 sq ft of state-of-art laboratory, incubation and collaboration space and was supported with funding from GBSLEP.
PHTA will soon occupy the top three floors of No.1 BHIC – the flagship building of the ambitious Birmingham Health Innovation Campus which is being delivered in partnership with experienced investor developers Bruntwood SciTech.
Prior to his role at the PHTA Professor Luigi “Gino” Martini was the Chief Scientific Officer for the Royal Pharmaceutical Society.
He is a registered practising Industrial Pharmacist and Fellow of the Royal Pharmaceutical Society who divides his time between the pharmaceutical industry and Academia as a visiting professor in pharmaceutical Innovation for a number of HEI’s in the UK.
Prior to that he spent over 17 years at GlaxoSmithKline Pharmaceuticals, Roche Product Ltd. and Shire Pharmaceuticals working in a variety of commercial, innovative technology-based and medical affairs roles, directing groups in the US, Europe and Emerging Markets.
Professor Martini has an MBA specialising in SME success and business failure awarded with distinction from the University of Liverpool.
He is a past chair of the Industrial Pharmacists Group of the Royal Pharmaceutical Society and past president of the European Industrial Pharmacists Group.
In 2016, Professor Martini was appointed a Fellow of the European Industrial Pharmacists Group.